Next Article in Journal
ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
Previous Article in Journal
Proteomic Profiling of Human Peripheral Blood Cell Targets of IgG Induced by SARS-CoV-2: Insights into Vaccine Safety
 
 
Article

Article Versions Notes

Vaccines 2025, 13(7), 695; https://doi.org/10.3390/vaccines13070695
Action Date Notes Link
article xml file uploaded 27 June 2025 12:15 CEST Original file -
article xml uploaded. 27 June 2025 12:15 CEST Update -
article pdf uploaded. 27 June 2025 12:15 CEST Version of Record https://www.mdpi.com/2076-393X/13/7/695/pdf-vor
article html file updated 27 June 2025 12:17 CEST Original file -
article xml file uploaded 8 July 2025 08:07 CEST Update -
article xml uploaded. 8 July 2025 08:07 CEST Update -
article pdf uploaded. 8 July 2025 08:07 CEST Updated version of record https://www.mdpi.com/2076-393X/13/7/695/pdf-vor
article html file updated 8 July 2025 08:09 CEST Update -
article xml file uploaded 10 July 2025 09:51 CEST Update -
article xml uploaded. 10 July 2025 09:51 CEST Update https://www.mdpi.com/2076-393X/13/7/695/xml
article pdf uploaded. 10 July 2025 09:51 CEST Updated version of record https://www.mdpi.com/2076-393X/13/7/695/pdf
article html file updated 10 July 2025 09:54 CEST Update https://www.mdpi.com/2076-393X/13/7/695/html
Back to TopTop